Evidence map›Paper›PMID 39155534›Full record

ArticleCancer science2024

A highly sensitive reporter system to monitor endogenous YAP1/TAZ activity and its application in various human cells.

Hiroki Hikasa, Kohichi Kawahara, Masako Inui, Yukichika Yasuki, Keita Yamashita, Kohei Otsubo, Shojiro Kitajima, Miki Nishio, Kazunari Arima, Motoyoshi Endo and 2 more

Abstract read
In one paragraph

Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroki HikasaDepartment of Biochemistry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.ORCID https://orcid.org/0009-0007-1703-6471
Kohichi KawaharaDivision of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Masako InuiDepartment of Biochemistry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Yukichika YasukiDepartment of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Keita YamashitaDepartment of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Kohei OtsuboDivision of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Shojiro KitajimaDepartment of Biochemistry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Miki NishioDivision of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Kazunari ArimaDepartment of Chemistry and Bioscience, Graduate School of Science and Engineering, Kagoshima University, Kagoshima, Japan.
Motoyoshi EndoDepartment of Molecular Biology, University of Occupational and Environmental Health, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-8287-2456
Masanori TairaFaculty of Science and Engineering, Chuo University, Tokyo, Japan.
Akira SuzukiDivision of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-5950-8808

Funding

Japan Agency for Medical Research and Development 23ama221117h0002Japan Agency for Medical Research and Development JP24ama121052Japan Agency for Medical Research and Development JP24ym0126801Japan Agency for Medical Research and Development JP24ym0126809Japan Society for the Promotion of Science 18K06232Japan Society for the Promotion of Science 21H04806Japan Society for the Promotion of Science 21K06830Japan Society for the Promotion of Science 23K07296Japan Society for the Promotion of Science JP16H06276
6 · The paper itself

Abstract

The activation of yes-associated protein 1 (YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ) has been implicated in both regeneration and tumorigenesis, thus representing a double-edged sword in tissue homeostasis. However, how the activity of YAP1/TAZ is regulated or what leads to its dysregulation in these processes remains unknown. To explore the upstream stimuli modulating the cellular activity of YAP1/TAZ, we developed a highly sensitive YAP1/TAZ/TEAD-responsive DNA element (YRE) and incorporated it into a lentivirus-based reporter cell system to allow for sensitive and specific monitoring of the endogenous activity of YAP1/TAZ in terms of luciferase activity in vitro and Venus fluorescence in vivo. Furthermore, by replacing YRE with TCF- and NF-κB-binding DNA elements, we demonstrated the applicability of this reporter system to other pathways such as Wnt/β-catenin/TCF- and IL-1β/NF-κB-mediated signaling, respectively. The practicality of this system was evaluated by performing cell-based reporter screening of a chemical compound library consisting of 364 known inhibitors, using reporter-introduced cells capable of quantifying YAP1/TAZ- and β-catenin-mediated transcription activities, which led to the identification of multiple inhibitors, including previously known as well as novel modulators of these signaling pathways. We further confirmed that novel YAP1/TAZ modulators, such as potassium ionophores, Janus kinase inhibitors, platelet-derived growth factor receptor inhibitors, and genotoxic stress inducers, alter the protein level or phosphorylation of endogenous YAP1/TAZ and the expression of their target genes. Thus, this reporter system provides a powerful tool to monitor endogenous signaling activities of interest (even in living cells) and search for modulators in various cellular contexts.

Indexed as

Adaptor Proteins, Signal TransducingGenes, ReporterPhosphoproteinsTranscription FactorsYAP-Signaling Proteinsbeta CateninHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsNF-kappa BResponse ElementsSignal TransductionTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsAdaptor Proteins, Signal Transducingbeta CateninIntracellular Signaling Peptides and ProteinsNF-kappa BPhosphoproteinsTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsTranscription FactorsWWTR1 protein, humanYAP1 protein, humanYAP-Signaling Proteinscell‐based screeninghighly sensitive reporter systemHippo‐YAP1/TAZ pathwaylentivirusYAP1/TAZ modulators

Identifiers

PMID39155534
PMCPMC11447953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.